Incyte Share Holder Equity 2006-2019 | INCY

Incyte share holder equity from 2006 to 2019. Share holder equity can be defined as the sum of preferred and common equity items
  • Incyte share holder equity for the quarter ending September 30, 2019 was $2.423B, a 34.37% increase year-over-year.
  • Incyte share holder equity for 2018 was $1.926B, a 18.11% increase from 2017.
  • Incyte share holder equity for 2017 was $1.631B, a 288.74% increase from 2016.
  • Incyte share holder equity for 2016 was $0.419B, a 145.08% increase from 2015.
Incyte Annual Share Holder Equity
(Millions of US $)
2018 $1,926
2017 $1,631
2016 $419
2015 $171
2014 $-82
2013 $-193
2012 $-175
2011 $-227
2010 $-89
2009 $-102
2008 $-221
2007 $-160
2006 $-85
2005 $-19
Incyte Quarterly Share Holder Equity
(Millions of US $)
Q3 2019 $2,423
Q2 2019 $2,247
Q1 2019 $2,086
Q4 2018 $1,926
Q3 2018 $1,803
Q2 2018 $1,733
Q1 2018 $1,628
Q4 2017 $1,631
Q3 2017 $1,758
Q2 2017 $1,027
Q1 2017 $966
Q4 2016 $419
Q3 2016 $370
Q2 2016 $297
Q1 2016 $228
Q4 2015 $171
Q3 2015 $89
Q2 2015 $55
Q1 2015 $-41
Q4 2014 $-82
Q3 2014 $-90
Q2 2014 $-171
Q1 2014 $-162
Q4 2013 $-193
Q3 2013 $29
Q2 2013 $-28
Q1 2013 $-164
Q4 2012 $-175
Q3 2012 $-220
Q2 2012 $-217
Q1 2012 $-249
Q4 2011 $-227
Q3 2011 $-181
Q2 2011 $-136
Q1 2011 $-104
Q4 2010 $-89
Q3 2010 $-129
Q2 2010 $-105
Q1 2010 $-114
Q4 2009 $-102
Q3 2009 $-199
Q2 2009 $-291
Q1 2009 $-257
Q4 2008 $-221
Q3 2008 $-177
Q2 2008 $-237
Q1 2008 $-197
Q4 2007 $-160
Q3 2007 $-141
Q2 2007 $-120
Q1 2007 $-104
Q4 2006 $-85
Q3 2006 $-66
Q2 2006 $-55
Q1 2006 $-38
Q4 2005 $-19
Q3 2005 $4
Q2 2005 $34
Q1 2005 $60
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $17.365B $1.882B
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis and for patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. They have a diverse and growing portfolio of product candidates, including both small and large molecules.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.901B 16.46
CSL (CSLLY) Australia $94.668B 0.00
Gilead Sciences (GILD) United States $79.957B 9.91
Vertex Pharmaceuticals (VRTX) United States $60.559B 61.81
Biogen (BIIB) United States $51.632B 8.86
Illumina (ILMN) United States $47.916B 52.57
Regeneron Pharmaceuticals (REGN) United States $42.333B 18.54
Alexion Pharmaceuticals (ALXN) United States $24.897B 12.30
Seattle Genetics (SGEN) United States $18.451B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.010B 0.00
Genmab (GNMSF) Denmark $14.044B 62.03
Alnylam Pharmaceuticals (ALNY) United States $13.305B 0.00
Galapagos (GLPG) Belgium $12.398B 31.94
Exact Sciences (EXAS) United States $11.656B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.384B 54.64
BeiGene (BGNE) Cayman Islands $10.251B 0.00
Sarepta Therapeutics (SRPT) United States $9.713B 0.00
Bio-Techne Corp (TECH) United States $8.362B 55.97
Guardant Health (GH) United States $7.827B 0.00
QIAGEN (QGEN) Netherlands $7.710B 25.14
BioNTech SE (BNTX) Germany $7.297B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.172B 18.23
Amarin (AMRN) Ireland $7.166B 0.00
Moderna (MRNA) United States $7.002B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.863B 0.00
Reata Pharmaceuticals (RETA) United States $6.547B 0.00
Exelixis (EXEL) United States $6.211B 17.47
Ascendis Pharma (ASND) Denmark $5.919B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.718B 0.00
Bluebird Bio (BLUE) United States $5.393B 0.00
Repligen (RGEN) United States $5.201B 94.25
China Biologic Products (CBPO) China $4.606B 25.94
MorphoSys AG (MOR) Germany $4.252B 0.00
Blueprint Medicines (BPMC) United States $3.983B 0.00
Mirati Therapeutics (MRTX) United States $3.842B 0.00
Immunomedics (IMMU) United States $3.741B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.609B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.517B 0.00
MyoKardia (MYOK) United States $3.475B 0.00
NeoGenomics (NEO) United States $3.404B 181.11
Adaptive Biotechnologies (ADPT) United States $3.403B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.292B 0.00
Alkermes (ALKS) Ireland $3.149B 0.00
Zai Lab (ZLAB) China $3.002B 0.00
Acceleron Pharma (XLRN) United States $2.986B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.978B 0.00
Halozyme Therapeutics (HALO) United States $2.950B 0.00
Genmab (GMAB) Denmark $2.938B 6.05
UniQure (QURE) Netherlands $2.907B 0.00
Emergent Biosolutions (EBS) United States $2.893B 28.74
Amicus Therapeutics (FOLD) United States $2.691B 0.00
Epizyme (EPZM) United States $2.326B 0.00
Arena Pharmaceuticals (ARNA) United States $2.319B 5.39
RA PHARMCTL INC (RARX) United States $2.217B 0.00
Myriad Genetics (MYGN) United States $2.151B 31.78
Denali Therapeutics (DNLI) United States $2.123B 0.00
Insmed (INSM) United States $2.027B 0.00
Principia Biopharma (PRNB) United States $1.879B 0.00
Fate Therapeutics (FATE) United States $1.837B 0.00
REGENXBIO (RGNX) United States $1.807B 0.00
Zymeworks (ZYME) Canada $1.737B 0.00
Arvinas (ARVN) United States $1.731B 0.00
Akcea Therapeutics (AKCA) United States $1.670B 0.00
Editas Medicine (EDIT) United States $1.643B 0.00
Ligand Pharmaceuticals (LGND) United States $1.625B 31.26
Intra-Cellular Therapies (ITCI) United States $1.476B 0.00
Innoviva (INVA) United States $1.470B 4.33
Dicerna Pharmaceuticals (DRNA) United States $1.449B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.424B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.409B 0.00
Coherus BioSciences (CHRS) United States $1.393B 0.00
Alector (ALEC) United States $1.371B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.197B 0.00
DBV Technologies S.A (DBVT) France $1.164B 0.00
Zealand Pharma (ZEAL) Denmark $1.149B 0.00
Codexis (CDXS) United States $1.087B 0.00
Sangamo Therapeutics (SGMO) United States $1.025B 0.00
Revance Therapeutics (RVNC) United States $1.009B 0.00
PHARMA MAR SA (PHMMF) Spain $0.979B 0.00
Pharming Group (PHGUF) Netherlands $0.955B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.902B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.902B 0.00
Heska (HSKA) United States $0.833B 212.78
Mesoblast (MESO) Australia $0.829B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.825B 6.94
Cellectis S.A (CLLS) France $0.783B 0.00
Vericel (VCEL) United States $0.779B 290.50
GENFIT S.A (GNFT) France $0.777B 0.00
Twist Bioscience (TWST) United States $0.765B 0.00
Adverum Biotechnologies (ADVM) United States $0.756B 0.00
Cytokineticsorporated (CYTK) United States $0.745B 0.00
Intellia Therapeutics (NTLA) United States $0.741B 0.00
ANI Pharmaceuticals (ANIP) United States $0.739B 12.61
Sorrento Therapeutics (SRNE) United States $0.727B 0.00
NantKwest (NK) United States $0.726B 0.00
UROGEN PHARMA (URGN) United States $0.723B 0.00
Retrophin (RTRX) United States $0.717B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
Cara Therapeutics (CARA) United States $0.676B 0.00
Anika Therapeutics (ANIK) United States $0.672B 21.81
AC Immune SA (ACIU) Switzerland $0.656B 15.17
Prothena (PRTA) Ireland $0.614B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.581B 0.00
Precision BioSciences (DTIL) United States $0.563B 0.00
Kadmon Holdings (KDMN) United States $0.558B 0.00
BioDelivery Sciences (BDSI) United States $0.541B 0.00
Agenus (AGEN) United States $0.529B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
Dynavax Technologies (DVAX) United States $0.517B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.516B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.509B 0.00
Arcus Biosciences (RCUS) United States $0.480B 0.00
Bellus Health (BLU) Canada $0.476B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.451B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.451B 3.12
AnaptysBio (ANAB) United States $0.438B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.419B 0.00
Merus (MRUS) Netherlands $0.415B 0.00
Kindred Biosciences (KIN) United States $0.401B 0.00
Pfenex (PFNX) United States $0.397B 0.00
Syros Pharmaceuticals (SYRS) United States $0.390B 0.00
Cue Biopharma (CUE) United States $0.386B 0.00
Gritstone Oncology (GRTS) United States $0.385B 0.00
PDL BioPharma (PDLI) United States $0.375B 9.37
Avid Bioservices (CDMO) United States $0.368B 0.00
Mersana Therapeutics (MRSN) United States $0.364B 0.00
Cel-Sci (CVM) United States $0.353B 0.00
Stemline Therapeutics (STML) United States $0.352B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Puma Biotechnology (PBYI) United States $0.347B 0.00
CytomX Therapeutics (CTMX) United States $0.342B 0.00
Cellular Biomedicine (CBMG) United States $0.340B 0.00
Inovio Pharmaceuticals (INO) United States $0.340B 0.00
Albireo Pharma (ALBO) United States $0.329B 0.00
MannKind (MNKD) United States $0.324B 0.00
VBI Vaccines (VBIV) United States $0.317B 0.00
Starpharma Holdings (SPHRY) Australia $0.314B 0.00
Compugen (CGEN) Israel $0.312B 0.00
Geron (GERN) United States $0.290B 0.00
OSMOTICA PHARM (OSMT) United States $0.289B 0.00
IVERIC Bio (ISEE) United States $0.279B 0.00
WAVE Life Sciences (WVE) Singapore $0.278B 0.00
Sutro Biopharma (STRO) United States $0.275B 0.00
ADMA Biologics Inc (ADMA) United States $0.272B 0.00
ChromaDex (CDXC) United States $0.266B 0.00
Kamada (KMDA) Israel $0.262B 7.65
Prometic Life Sciences (LMNL) Canada $0.256B 0.00
Biofrontera AG (BFRA) Germany $0.255B 0.00
Seres Therapeutics (MCRB) United States $0.244B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.236B 0.00
Affimed (AFMD) Germany $0.226B 0.00
Theratechnologies (THTX) Canada $0.225B 0.00
Cerecor (CERC) United States $0.224B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.223B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.217B 0.00
Exicure (XCUR) United States $0.213B 0.00
XOMA (XOMA) United States $0.209B 0.00
Athersys (ATHX) United States $0.201B 0.00
Fortress Biotech (FBIO) United States $0.199B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.198B 0.00
Protagonist Therapeutics (PTGX) United States $0.195B 0.00
Arbutus Biopharma (ABUS) Canada $0.189B 0.00
Five Prime Therapeutics (FPRX) United States $0.187B 0.00
ARAVIVE, INC (ARAV) United States $0.187B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.185B 0.00
Alcobra (ARCT) United States $0.185B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.184B 0.00
CorMedix Inc (CRMD) United States $0.180B 0.00
Spero Therapeutics (SPRO) United States $0.173B 0.00
TELA Bio (TELA) United States $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Palatin Technologies (PTN) United States $0.167B 4.56
Menlo Therapeutics (MNLO) United States $0.163B 0.00
Dyadic (DYAI) United States $0.161B 0.00
Novavax (NVAX) United States $0.154B 0.00
Selecta Biosciences (SELB) United States $0.151B 0.00
Applied Genetic Technologies (AGTC) United States $0.148B 0.00
Verastem (VSTM) United States $0.146B 0.00
Windtree Therapeutics (WINT) United States $0.145B 0.00
Strongbridge Biopharma (SBBP) United States $0.137B 3.65
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Abeona Therapeutics (ABEO) United States $0.130B 0.00
Enzo Biochem (ENZ) United States $0.129B 0.00
Arsanis (XFOR) United States $0.128B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.126B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.125B 6.43
Aptinyx (APTX) United States $0.121B 0.00
VTv Therapeutics (VTVT) United States $0.119B 0.00
Liquidia Technologies (LQDA) United States $0.114B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
OvaScience (MLND) United States $0.111B 0.00
Clearside Biomedical (CLSD) United States $0.110B 0.00
Antibe Therapeutics (ATBPF) Canada $0.109B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.106B 0.00
SESEN BIO, INC (SESN) United States $0.105B 0.00
Acorda Therapeutics (ACOR) United States $0.103B 0.00
Synlogic (SYBX) United States $0.103B 0.00
Proteostasis Therapeutics (PTI) United States $0.099B 0.00
Emmaus Life Sciences (EMMA) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.082B 0.00
Trevena (TRVN) United States $0.081B 0.00
Orgenesis (ORGS) United States $0.081B 5.23
Vaccinex (VCNX) United States $0.075B 0.00
NewLink Genetics (NLNK) United States $0.074B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Curis (CRIS) United States $0.057B 0.00
Idera Pharmaceuticals (IDRA) United States $0.057B 0.00
DiaMedica Therapeutics (DMAC) United States $0.056B 0.00
Protalix BioTherapeutics (PLX) Israel $0.054B 0.00
AquaBounty Technologies (AQB) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Evogene (EVGN) Israel $0.044B 0.00
Soligenix (SNGX) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Celsion (CLSN) United States $0.037B 0.00
BioCardia (BCDA) United States $0.035B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Bionano Genomics (BNGO) United States $0.033B 0.00
Entera Bio (ENTX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Pulmatrix (PULM) United States $0.031B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Unum Therapeutics (UMRX) United States $0.030B 0.00
Novogen (KZIA) Australia $0.029B 0.00
VIVUS (VVUS) United States $0.029B 0.00
AmpliPhi Biosciences (ARMP) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.028B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Advaxis (ADXS) United States $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.019B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Cleveland BioLabs (CBLI) United States $0.010B 0.00
IBio (IBIO) United States $0.008B 0.00
BioPharmX (BPMX) United States $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
Neuralstem (SNCA) United States $0.005B 0.00